A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2018
At a glance
- Drugs Desoximetasone (Primary)
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- Sponsors Taro Pharmaceuticals USA
- 26 Jan 2018 Status changed from active, no longer recruiting to completed.
- 16 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Jul 2017.
- 16 Mar 2017 Status changed from recruiting to active, no longer recruiting.